Department of Pharmacology, University of Virginia, Charlottesville, Virginia 22908, USA.
J Biol Chem. 2010 Nov 5;285(45):34839-49. doi: 10.1074/jbc.M110.128827. Epub 2010 Sep 1.
The Src homology 2 domain-containing inositol 5'-phosphatase 1 (SHIP1) dephosphorylates phosphatidylinositol 3,4,5-trisphosphate to phophatidylinositol 3,4-bisphosphate in hematopoietic cells to regulate multiple cell signaling pathways. SHIP1 can be phosphorylated by the cyclic AMP-dependent protein kinase (PKA), resulting in an increase in SHIP1 activity (Zhang, J., Walk, S. F., Ravichandran, K. S., and Garrison, J. C. (2009) J. Biol. Chem. 284, 20070-20078). Using a combination of approaches, we identified the serine residue regulating SHIP1 activity. After mass spectrometric identification of 17 serine and threonine residues on SHIP1 as being phosphorylated by PKA in vitro, studies with truncation mutants of SHIP1 narrowed the phosphorylation site to the catalytic region between residues 400 and 866. Of the two candidate phosphorylation sites located in this region (Ser(440) and Ser(774)), only mutation of Ser(440) to Ala abolished the ability of PKA to phosphorylate the purified, catalytic domain of SHIP1 (residues 401-866). Mutation of Ser(440) to Ala in full-length SHIP1 abrogated the ability of PKA to increase the activity of SHIP1 in mammalian cells. Using flow cytometry, we found that the PKA activator, Sp-adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt hydrate (Sp-cAMPS) blunted the phosphorylation of Akt downstream of B cell antigen receptor engagement in SHIP1-null DT40 B lymphocytes expressing native mouse SHIP1. The inhibitory effect of Sp-cAMPS was absent in cells expressing the S440A mutant of SHIP1. These results suggest that activation of SHIP1 by PKA via phosphorylation on Ser(440) is an important regulatory event in hematopoietic cells.
Src 同源 2 结构域包含肌醇 5'-磷酸酶 1(SHIP1)在造血细胞中将磷脂酰肌醇 3,4,5-三磷酸去磷酸化为磷脂酰肌醇 3,4-二磷酸,以调节多种细胞信号通路。SHIP1 可被环 AMP 依赖性蛋白激酶(PKA)磷酸化,导致 SHIP1 活性增加(Zhang,J.,Walk,S. F.,Ravichandran,K. S.,和 Garrison,J. C.(2009)J. Biol. Chem. 284,20070-20078)。通过多种方法的结合,我们确定了调节 SHIP1 活性的丝氨酸残基。在体外鉴定出 SHIP1 上的 17 个丝氨酸和苏氨酸残基被 PKA 磷酸化后,用 SHIP1 的截断突变体进行的研究将磷酸化位点缩小到位于残基 400 和 866 之间的催化区域。在该区域中存在的两个候选磷酸化位点(Ser(440)和 Ser(774))中,只有 Ser(440)突变为丙氨酸才能使 PKA 失去对纯化的、催化结构域的 SHIP1(残基 401-866)的磷酸化能力。在全长 SHIP1 中 Ser(440)突变为丙氨酸会使 PKA 丧失在哺乳动物细胞中增加 SHIP1 活性的能力。通过流式细胞术,我们发现 PKA 激活剂 Sp-腺苷 3',5'-环单磷酸硫代磷酸三乙酯盐水合物(Sp-cAMPS)可减弱 B 细胞抗原受体结合后 Akt 的磷酸化,在表达天然小鼠 SHIP1 的 SHIP1 缺失 DT40 B 淋巴细胞中。在表达 SHIP1 的 S440A 突变体的细胞中,Sp-cAMPS 的抑制作用不存在。这些结果表明,PKA 通过 Ser(440)的磷酸化激活 SHIP1 是造血细胞中的一个重要调节事件。